Agenda

18th Texas Update in Cardiovascular Advancements | Denton A. Cooley Auditorium

All presentations are followed by Q&A with the speaker

7:30 am    Continental Breakfast and Exhibits

8:00         Welcome and Introductions |  James T. Willerson, MD

8:15          PCKS9 Inhibitors: Are They Alternatives to Treating Elevated LDLs in Patients Intolerant of Statins? | Vijay Nambi, MD, PhD

8:45         Non-Invasive Imaging of Vascular Inflammation | Darren Woodside, PhD

9:15          Latest Development in Treating Patients with TAVR | David Fish, MD

9:45         Hormonal Therapy for Post Menopaused Women at High Risk of CAD: What is Best? | Stephanie Coulter, MD

10:15        Closure Devices for Mitral Valve Regurgitation, ASDs, and VSDs:What Progress Has Been Made? | Guilherme Silva, MD

11:00        Advances in Radiofrequency Ablation of Atrial Fibrillation |Abdi Rasekh, MD

11:30        Questions of the Speakers


Presentation of Ray C. Fish Award and Luncheon | Texas Heart Institute The Ansary Atrium

Noon     Introduction of the Ray C. Fish Award and Recipient |  James T. Willerson, MD

12:05       Presentation of the Ray C. Fish Award | James T. Willerson, MD

12:15        Luncheon in honor of Ray C. Fish Award Recipient | Emerson Perin, MD, PhD


18th Texas Update in Cardiovascular Advancements | Denton A. Cooley Auditorium

1:15          Ray C. Fish Lecture:  Cell Therapy for the Heart: A Journey to Approval Emerson Perin, MD, PhD Medical Director, Texas Heart Institute  (Houston, Texas)

2:00        Treating Patients with CHF and LV Systolic Dysfunction by Treating Mitral Regurgitation | Andrew B. Civitello, MD

2:30        Update on Treatment of DVT | Zvonimir Krajcer, MD

3:00        Treating CHF by Stimulating Cardiogenesis Directly | James F. Martin, MD, PhD

3:30        Questions of the Speakers

3:45        Final Comments and Adjourn |  James T. Willerson, MD

 

Downloadable Agenda

Quick Links